US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6183746B1
(en)
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
US6013258A
(en)
*
|
1997-10-09 |
2000-01-11 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
AU5532699A
(en)
*
|
1998-09-05 |
2000-03-27 |
Seung Jin Lee |
Biodegradable particulate polymeric preparation and process for producing thereof
|
KR20000022894A
(ko)
*
|
1998-09-05 |
2000-04-25 |
이승진 |
생분해성 고분자 미립자형 제제 및 그 제조방법
|
DE19848849A1
(de)
*
|
1998-10-22 |
2000-04-27 |
Knoll Ag |
Verfahren zur Herstellung von festen, sphärischen Formen, enthaltend eine biologisch aktive Substanz
|
EP1058539A1
(de)
*
|
1999-01-06 |
2000-12-13 |
Korea Research Institute Of Chemical Technology |
Methode zur herstellung eines pharmazeutisch aktiven bestandteils beinhaltend einen wasserunlöslichen wirkstoff sowie eine pharmazeutische zusammensetzung zur oralen verabreichung die diesen bestandteil enthält
|
US6159491A
(en)
*
|
1999-02-12 |
2000-12-12 |
Biovector Technologies, Inc. |
Prolonged release bioadhesive vaginal gel dosage form
|
KR100372751B1
(ko)
*
|
1999-11-16 |
2003-02-17 |
한국과학기술원 |
생체조직공학용 다공성 생분해성 고분자 지지체의 제조방법
|
ES2261195T3
(es)
*
|
1999-04-05 |
2006-11-16 |
Mannkind Corporation |
Metodo de formacion de particulas finas.
|
WO2000062759A1
(en)
*
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Dry, mouldable drug formulation
|
US7371400B2
(en)
|
2001-01-02 |
2008-05-13 |
The General Hospital Corporation |
Multilayer device for tissue engineering
|
AU772484B2
(en)
*
|
1999-04-30 |
2004-04-29 |
Massachusetts General Hospital |
Fabrication of vascularized tissue using microfabricated two-dimensional molds
|
US7759113B2
(en)
*
|
1999-04-30 |
2010-07-20 |
The General Hospital Corporation |
Fabrication of tissue lamina using microfabricated two-dimensional molds
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
US6444223B1
(en)
*
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
JP2003501375A
(ja)
*
|
1999-06-04 |
2003-01-14 |
アルザ・コーポレーション |
移植可能なゲル組成物および製造方法
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
EP1074248A1
(de)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Verabreichungssystem für biologisches Material
|
US6822086B1
(en)
*
|
1999-08-09 |
2004-11-23 |
The General Hospital Corporation |
Drug-carrier complexes and methods of use thereof
|
US8106098B2
(en)
*
|
1999-08-09 |
2012-01-31 |
The General Hospital Corporation |
Protein conjugates with a water-soluble biocompatible, biodegradable polymer
|
WO2001010416A1
(en)
*
|
1999-08-11 |
2001-02-15 |
Alkermes Controlled Therapeutics, Inc. |
Method of delivering a chemotherapeutic agent to a solid tumor
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
AU1226901A
(en)
*
|
1999-10-22 |
2001-05-08 |
Amgen, Inc. |
Biodegradable microparticles with novel erythropoietin stimulating protein
|
WO2001047572A2
(en)
*
|
1999-12-29 |
2001-07-05 |
Advanced Cardiovascular Systems, Inc. |
Device and active component for inhibiting formation of thrombus-inflammatory cell matrix
|
US7029700B2
(en)
*
|
2000-01-14 |
2006-04-18 |
Brown University Research Foundation |
Micronized freeze-dried particles
|
US7833549B2
(en)
*
|
2000-01-19 |
2010-11-16 |
Mannkind Corporation |
Dry powder formulations of antihistamine for nasal administration
|
EP1261427B1
(de)
*
|
2000-03-02 |
2011-03-02 |
Microchips, Inc. |
Mikromechanische geräte und verfahren zur speicherung und zur selektiven exposition von chemikalien
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US6582713B2
(en)
|
2000-04-06 |
2003-06-24 |
Univ. Of Colorado - Colorado Springs |
Compositions and methods for promoting wound healing
|
US7776021B2
(en)
|
2000-04-28 |
2010-08-17 |
The Charles Stark Draper Laboratory |
Micromachined bilayer unit for filtration of small molecules
|
DE60127139T2
(de)
*
|
2000-07-14 |
2007-12-13 |
Novo Nordisk A/S |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
KR100867392B1
(ko)
*
|
2000-08-15 |
2008-11-06 |
더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 |
마이크로입자
|
US6565888B1
(en)
|
2000-08-23 |
2003-05-20 |
Alkermes Controlled Therapeutics, Inc. |
Methods and compositions for the targeted delivery of biologically active agents
|
AU8734901A
(en)
*
|
2000-09-01 |
2002-03-13 |
Palmaya Pty Ltd |
Slow release pharmaceutical preparation and method of administering same
|
US7666445B2
(en)
|
2000-10-20 |
2010-02-23 |
The Trustees Of The University Of Pennsylvania |
Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use
|
WO2002042325A2
(en)
|
2000-10-31 |
2002-05-30 |
Zycos Inc. |
Cyp1b1 nucleic acids and methods of use
|
WO2002062352A2
(en)
*
|
2001-02-07 |
2002-08-15 |
Durect Corporation |
Devices and methods for management of bone density
|
PT1392248E
(pt)
*
|
2001-05-23 |
2007-10-11 |
Hexal Ag |
Processo para a preparação de implantes por meio da preparação de um homogeneizado sem solvente
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
US7268190B2
(en)
*
|
2001-08-03 |
2007-09-11 |
Toray Industries, Inc. |
Resin composition comprising polylactic acid and polyacetal and a molded article, film, and fiber each comprising the same
|
US7687053B2
(en)
*
|
2001-08-20 |
2010-03-30 |
Boston Scientific Scimed, Inc. |
Embolic compositions with non-cyanoacrylate rheology modifying agents
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
US7190781B2
(en)
*
|
2002-01-04 |
2007-03-13 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Message transfer part point code mapping method and node
|
DE60323936D1
(de)
*
|
2002-01-14 |
2008-11-20 |
Gen Hospital Corp |
Bioabbaubare polyketale, verfahren zu ihrer herstellung sowie ihre verwendung
|
WO2003070905A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Zycos, Inc. |
Electroporation methods for introducing bioactive agents into cells
|
US8728510B1
(en)
|
2002-03-15 |
2014-05-20 |
Advanced Cardiovascular Systems, Inc. |
Biocompatible carrier containing a bioadhesive material
|
WO2003080149A2
(en)
|
2002-03-20 |
2003-10-02 |
Mannkind Corporation |
Inhalation apparatus
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
CA2492803C
(en)
*
|
2002-07-19 |
2013-11-05 |
The General Hospital Corporation |
Oxime conjugates and methods for their formation and use
|
GB2399084B
(en)
*
|
2002-07-30 |
2007-01-31 |
Univ Liverpool |
Porous beads and method of production thereof
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
AU2003279070A1
(en)
*
|
2002-09-30 |
2004-04-23 |
Acusphere Inc |
Sustained release porous microparticles for inhalation
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
ATE439039T1
(de)
|
2003-01-16 |
2009-08-15 |
Gen Hospital Corp |
Verwendung von dreidimensionalen, mikrogefertigten, mittels gewebetechnologie hergestellten systemen für pharmakologische anwendungen
|
US7658998B2
(en)
*
|
2003-01-22 |
2010-02-09 |
Alkermes Controlled Therapeutics, Inc. |
Method of preparing sustained release microparticles
|
DE10303584A1
(de)
*
|
2003-01-30 |
2004-08-12 |
Stauss, Robert, Dr. |
Verwendung von Erythropoietin (EPO) als ein Beschichtungsmaterial auf medizinischen Implantaten
|
US7736391B2
(en)
|
2003-02-06 |
2010-06-15 |
Tonaba Healthscience Ii, Llc |
Cosmetic and reconstructive prostheses with a microencapsulated biologically compatible rupture indicator for sustained release and methods of detecting compromise of a prosthesis
|
WO2004084819A2
(en)
*
|
2003-03-19 |
2004-10-07 |
University Of Kentucky Research Foundation |
Poly(acryloyl-hydroxyethyl starch)-plga composite microspheres
|
US7051485B2
(en)
*
|
2003-04-29 |
2006-05-30 |
Greg Burnette |
Ceiling panel system
|
US7960166B2
(en)
|
2003-05-21 |
2011-06-14 |
The General Hospital Corporation |
Microfabricated compositions and processes for engineering tissues containing multiple cell types
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
ATE507845T1
(de)
*
|
2003-09-05 |
2011-05-15 |
Gen Hospital Corp |
Polyacetal-arzneimittelkonjugate als freisetzungssystem
|
EP1667659A1
(de)
*
|
2003-09-30 |
2006-06-14 |
Acusphere, Inc. |
Injizierbare, orale oder topische pharmazeutische formulierungen mit verzögerter freisetzung
|
EP1675571A2
(de)
*
|
2003-09-30 |
2006-07-05 |
Spherics, Inc. |
Therapeutische biologische wirkstoffe in nanoteilchenform
|
US7309500B2
(en)
*
|
2003-12-04 |
2007-12-18 |
The Board Of Trustees Of The University Of Illinois |
Microparticles
|
PL2233150T3
(pl)
*
|
2003-12-30 |
2017-06-30 |
Bader |
Erytropoetyna do zastosowania w leczeniu ran lub transplantacji komórek
|
US8329203B2
(en)
*
|
2004-01-12 |
2012-12-11 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
US8221778B2
(en)
|
2005-01-12 |
2012-07-17 |
The Trustees Of The University Of Pennsylvania |
Drug-containing implants and methods of use thereof
|
CA2553254C
(en)
*
|
2004-01-12 |
2013-12-17 |
The Trustees Of The University Of Pennsylvania |
Long-term delivery formulations and methods of use thereof
|
WO2005072702A2
(en)
*
|
2004-01-20 |
2005-08-11 |
Alkermes Controlled Therapeutics, Inc. |
Method for milling frozen microparticles
|
US20050188921A1
(en)
*
|
2004-02-27 |
2005-09-01 |
Anthony Malone |
Matrix assisted pulsed-laser evaporation technique for coating a medical device and associated system and medical device
|
ATE413398T1
(de)
*
|
2004-04-08 |
2008-11-15 |
Wyeth Corp |
Thioamidderivate als progesteronrezeptormodulatoren
|
US7514466B2
(en)
|
2004-04-27 |
2009-04-07 |
Wyeth |
Purification of progesterone receptor modulators
|
CA2565296C
(en)
*
|
2004-04-30 |
2014-06-03 |
Abraxis Bioscience, Inc. |
Sustained-release microspheres and methods of making and using same
|
EP1773293B1
(de)
*
|
2004-06-17 |
2015-04-15 |
Endo Pharmaceuticals Solutions Inc. |
Zusammensetzungen und verfahren zur behandlung von zentraler vorzeitiger pubertät
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
PT1781264E
(pt)
|
2004-08-04 |
2013-10-16 |
Evonik Corp |
Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
JP5078014B2
(ja)
|
2004-08-20 |
2012-11-21 |
マンカインド コーポレイション |
ジケトピペラジン合成の触媒反応
|
HUE026797T2
(en)
|
2004-08-23 |
2016-07-28 |
Mannkind Corp |
Diceto-piperazine salts for drug delivery
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US8367099B2
(en)
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
US8312836B2
(en)
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
WO2006036982A2
(en)
*
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Drug delivery coating for use with a stent
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
WO2006036969A2
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Formation of barrier layer
|
CN101437856A
(zh)
*
|
2004-10-14 |
2009-05-20 |
塔夫茨大学信托人 |
可电化学降解的聚合物
|
US7748343B2
(en)
|
2004-11-22 |
2010-07-06 |
The Board Of Trustees Of The University Of Illinois |
Electrohydrodynamic spraying system
|
WO2006078841A1
(en)
*
|
2005-01-21 |
2006-07-27 |
President And Fellows Of Harvard College |
Systems and methods for forming fluidic droplets encapsulated in particles such as colloidal particles
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
JP4584331B2
(ja)
*
|
2005-03-11 |
2010-11-17 |
インデバス ファーマシューティカルズ、インク. |
オクトレオチドの放出制御製剤
|
US7759312B2
(en)
*
|
2005-03-11 |
2010-07-20 |
Endo Pharmaceuticals Solutions Inc. |
Delivery of dry formulations of octreotide
|
KR20120060245A
(ko)
|
2005-09-14 |
2012-06-11 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US8574627B2
(en)
|
2006-11-06 |
2013-11-05 |
Atrium Medical Corporation |
Coated surgical mesh
|
US9427423B2
(en)
*
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
CA2626030A1
(en)
|
2005-10-15 |
2007-04-26 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
US7669732B2
(en)
*
|
2005-10-25 |
2010-03-02 |
Imi Cornelius Inc. |
Cup lid dispenser
|
EP2497484A3
(de)
|
2006-02-22 |
2012-11-07 |
MannKind Corporation |
Verfahren zur Verbesserung der pharmazeutischen Eigenschaften von Mikropartikeln mit Diketopiperazin und einem Wirkstoff
|
EP2012751A4
(de)
*
|
2006-03-21 |
2010-11-24 |
Morehouse School Of Medicine |
Neue nanopartikel zur wirkstofffreisetzung
|
US8747870B2
(en)
|
2006-04-20 |
2014-06-10 |
University Of Utah Research Foundation |
Polymeric compositions and methods of making and using thereof
|
EP2012803A4
(de)
*
|
2006-04-20 |
2012-08-01 |
Univ Utah Res Found |
Polymerzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
|
GB0613333D0
(en)
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
US20080075777A1
(en)
*
|
2006-07-31 |
2008-03-27 |
Kennedy Michael T |
Apparatus and methods for preparing solid particles
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
ITMI20061538A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Impianti sottocutanei in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
PE20090167A1
(es)
*
|
2007-03-09 |
2009-02-11 |
Wyeth Corp |
Sintesis y caracterizacion de la forma iii polimorfica de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il)tiazol-4-il)benzonitrilo
|
CA2685397C
(en)
*
|
2007-04-27 |
2016-07-26 |
Endo Pharmaceuticals Solutions Inc. |
Implant device release agents and methods of using same
|
PT2868315T
(pt)
|
2007-12-04 |
2017-09-04 |
Remedy Pharmaceuticals Inc |
Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
KR101616246B1
(ko)
|
2008-01-25 |
2016-05-02 |
그뤼넨탈 게엠베하 |
약제학적 투여형
|
MX2010012039A
(es)
*
|
2008-05-09 |
2010-11-30 |
Gruenenthal Gmbh |
Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
|
WO2009143404A1
(en)
*
|
2008-05-23 |
2009-11-26 |
Wyeth |
Piperazine metabotropic glutamate receptor 5 (mglur5) negative allosteric modulators for anxiety/depression
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
EP3281663B8
(de)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Atemluftbetriebener trockenpulverinhalator zur verabreichung von medikamenten
|
US9364619B2
(en)
|
2008-06-20 |
2016-06-14 |
Mannkind Corporation |
Interactive apparatus and method for real-time profiling of inhalation efforts
|
JP5622725B2
(ja)
|
2008-06-25 |
2014-11-12 |
エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド.Endo Pharmaceuticals Solutionsinc. |
エキセナチド及び他のポリペプチド類の持続的送達
|
UA104866C2
(uk)
*
|
2008-06-25 |
2014-03-25 |
Ендо Фармас'Ютікалз Солюшнз Інк. |
Імплантат октреотиду, який містить вивільняючу речовину
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
CL2009002167A1
(es)
*
|
2008-12-10 |
2010-10-15 |
Mersana Therapeutics Inc |
Formulacion farmaceutica para administracion endovenosa que comprende un compuesto derivado de conjugados de camptotecina-polimero biocompatibles y biodegradables, un agente de estabilizacion, uno o varios tampones y un tensoactivo, util para el tratamiento del cancer.
|
WO2010066203A1
(en)
|
2008-12-10 |
2010-06-17 |
Anhui Zhongren Technology Co., Ltd. |
Controlled releasing composition
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
WO2010085607A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Surmodics Pharmaceuticals, Inc. |
Continuous double emulsion process for making microparticles
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010144789A2
(en)
|
2009-06-12 |
2010-12-16 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
MX2012000317A
(es)
|
2009-07-22 |
2012-02-08 |
Gruenenthal Gmbh |
Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
|
RU2015138422A
(ru)
|
2009-07-22 |
2018-12-25 |
Грюненталь Гмбх |
Стабильная при окислении, прочная на излом лекарственная форма
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
EP2470019A4
(de)
*
|
2009-08-25 |
2013-03-13 |
Cardiokine Biopharma Llc |
Zusammensetzungen zur verabreichung nichtlöslicher mittel
|
RU2545865C2
(ru)
*
|
2009-09-22 |
2015-04-10 |
Евоник Корпорейшн |
Имплантируемые устройства с различными вариантами загрузки биологически активного компонента
|
CA2778698A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
WO2011095314A2
(en)
*
|
2010-02-03 |
2011-08-11 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
AU2011271097B2
(en)
|
2010-06-21 |
2014-11-27 |
Mannkind Corporation |
Dry powder drug delivery system and methods
|
US10322213B2
(en)
|
2010-07-16 |
2019-06-18 |
Atrium Medical Corporation |
Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
|
ES2487244T3
(es)
|
2010-09-02 |
2014-08-20 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación que comprende un polímero aniónico
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
US10669522B2
(en)
|
2011-02-07 |
2020-06-02 |
Life Technologies Corporation |
Compositions and methods for stabilizing susceptible compounds
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
WO2012172449A1
(en)
|
2011-06-13 |
2012-12-20 |
Pfizer Inc. |
Lactams as beta secretase inhibitors
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AU2012292418B2
(en)
|
2011-07-29 |
2017-02-16 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
CA2839123A1
(en)
|
2011-07-29 |
2013-02-07 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
WO2013025418A1
(en)
*
|
2011-08-15 |
2013-02-21 |
Morehouse School Of Medicine |
Delivery system for specifically targeting cancer cells and method of use thereof
|
KR20140095483A
(ko)
|
2011-10-24 |
2014-08-01 |
맨카인드 코포레이션 |
통증을 치료하기 위한 방법 및 조성물
|
EP2790667B1
(de)
|
2011-12-16 |
2017-03-22 |
DSM IP Assets B.V. |
Verfahren zur herstellung eines arzneimittelabgabesystems basierend auf einem polymer, umfassend einen dispergierten bioaktiven wirkstoff
|
MX356421B
(es)
|
2012-02-28 |
2018-05-29 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
|
CN104394851B
(zh)
|
2012-04-18 |
2017-12-01 |
格吕伦塔尔有限公司 |
抗篡改和抗剂量‑倾泻药物剂型
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
DK2872205T3
(en)
|
2012-07-12 |
2017-02-27 |
Mannkind Corp |
DRY POWDER FORMAL ADMINISTRATION SYSTEM
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
KR102499439B1
(ko)
|
2013-03-15 |
2023-02-13 |
맨카인드 코포레이션 |
미세결정성 디케토피페라진 조성물 및 방법
|
AR096438A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
|
CA2907950A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
BR112016000194A8
(pt)
|
2013-07-12 |
2019-12-31 |
Gruenenthal Gmbh |
forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
|
WO2015010092A1
(en)
|
2013-07-18 |
2015-01-22 |
Mannkind Corporation |
Heat-stable dry powder pharmaceutical compositions and methods
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
CN105934241B
(zh)
|
2013-11-26 |
2020-06-05 |
格吕伦塔尔有限公司 |
通过低温研磨制备粉末状药物组合物
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
WO2015173195A1
(en)
|
2014-05-12 |
2015-11-19 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
JP2017516789A
(ja)
|
2014-05-26 |
2017-06-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エタノール過量放出に対して防護されている多粒子
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
EP3285745A1
(de)
|
2015-04-24 |
2018-02-28 |
Grünenthal GmbH |
Manipulationssichere darreichungsform mit sofortiger freisetzung und widerstand gegen lösungsmittelextraktion
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|
US10953103B2
(en)
|
2015-11-06 |
2021-03-23 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V |
Composition comprising a biocompatible and biodegradable polymer, nanocarriers and a drug and methods of making and using the same
|